Abstract Number: 2227 • 2014 ACR/ARHP Annual Meeting
Physical Impairment in Patients with Idiopathic Inflammatory Myopathies Is Predicted By the American College of Rheumatology Functional Status Measure
Background/Purpose The American College of Rheumatology classification criteria of functional status (ACR-FS) in Rheumatoid Arthritis is used as a measure of the consequences of impairment…Abstract Number: 2228 • 2014 ACR/ARHP Annual Meeting
Has MRI an Added Value over Serum Creatine Kinase Measurement in Myositis?
Background/Purpose MRI is widely used to assess inflammation in myositis. Muscle edema on short tau inversion recovery (STIR) sequences is thought to reflect active inflammation.…Abstract Number: 2229 • 2014 ACR/ARHP Annual Meeting
How Often Are Clinically Amyopathic Dermatomyositis Patients Truly Amyopathic?
Background/Purpose: Juvenile dermatomyositis (JDM) is a chronic inflammatory disorder primarily involving the skin and striated muscle. Classic JDM presents with rash, proximal muscle weakness, and…Abstract Number: 2230 • 2014 ACR/ARHP Annual Meeting
Treatment of Symptomatic Knee Osteoarthritis with Oral Salmon Calcitonin: Results from Two Phase 3 Randomized Clinical Trials
Background/Purpose: To evaluate the structure-modifying and symptom efficacy, as well as safety and tolerability of oral salmon calcitonin (sCT) formulated with a 5-CNAC carrier (a…Abstract Number: 2191 • 2014 ACR/ARHP Annual Meeting
Intravenous Sodium Thiosulfate for Treatment of Refractory Calcinosis in Rheumatic Disease
Background/Purpose: Calcinosis, or dystrophic calcification, is a poorly understood, debilitating condition commonly manifested in connective tissue diseases such as scleroderma and polymyositis. Despite treatment of…Abstract Number: 2192 • 2014 ACR/ARHP Annual Meeting
Successful Therapy with Intravenous Sodium Thiosulfate for Adult Dermatomyositis Associated Calcinosis
Background/Purpose: Calcinosis cutis is the deposition of insoluble calcium salts in skin or subcutaneous tissue. In cases related to CTD, presents with normal calcium/phosphorus metabolism,…Abstract Number: 2193 • 2014 ACR/ARHP Annual Meeting
Prevalence of Raynaud’s Phenomenon and Nailfold Capillaroscopic Abnormalities in Fabry’s Disease: A Cross-Sectional Study
Background/Purpose: Fabry's disease (FD) is a lysosomal disorder leading to progressive systemic involvement, including neurologic and vascular. We hypothesize that the microangiopathy observed in FD…Abstract Number: 2194 • 2014 ACR/ARHP Annual Meeting
Blue Digit Syndrome: The Rheumatologist’s Perspective
Background/Purpose: Blue or purple digit syndrome (or sign) is a cutaneous manifestation of multiple diseases that produce acute or subacute ischemic compromise in one or…Abstract Number: 2195 • 2014 ACR/ARHP Annual Meeting
Eculizumab Treatment of Malignant Atrophic Papulosis (Köhlmeier-Degos Disease): World Experience to Date
Background/Purpose Malignant atrophic papulosis (MAP) is an obliterative vasculopathy which presents with distinctive cutaneous lesions but can progress over months to years to systemic disease…Abstract Number: 2196 • 2014 ACR/ARHP Annual Meeting
Treprostinil Use in Malignant Atrophic Papulosis (Köhlmeier-Degos Disease): Review of Worldwide Experience to Date
Background/Purpose Malignant atrophic papulosis (MAP) is a rare thrombo-occlusive vasculopathy that presents with cutaneous only lesions but can progress after months or years to rapidly fatal systemic…Abstract Number: 2197 • 2014 ACR/ARHP Annual Meeting
Malignant Atrophic Papulosis (MAP) Complicating Connective Tissue Diseases (CTDs)
Background/Purpose Malignant Atrophic Papulosis (MAP) is a rare vasculopathy of unknown etiology commonly presenting with cutaneous lesions, but can progress to multisystem disease with a…Abstract Number: 2198 • 2014 ACR/ARHP Annual Meeting
The Aromatase Inhibitor Induced Musculoskeletal Syndrome: Is There a Potential Role of Osteoporosis Therapy and Menopause Timing?
Background/Purpose: Aromatase Inhibitor (AI) therapy is the most effective hormonal treatment in post-menopausal estrogen receptor (ER) positive breast cancer. These patients may be seen by…Abstract Number: 2199 • 2014 ACR/ARHP Annual Meeting
Intravenous Immunoglobulin Therapy for Secondary Hemophagocytic Lymphohistiocytosis : A Retrospective Study of 46 Patients
Background/Purpose Intravenous Immunoglobulins (IVIg) have been reported as giving good results in infectious, but also auto-immune related forms of hemophagocytic lymphohistiocytosis (HLH), but only in…Abstract Number: 2200 • 2014 ACR/ARHP Annual Meeting
Elevated Serum Ferritin Levels in Adult Inpatients As a Predictor of in-Hospital Mortality and Association with Macrophage Activation Syndrome
Background/Purpose Macrophage Activation Syndrome (MAS) is a syndrome similar to Familial Hemophagocytic Lymphohistiocytosis (HLH) characterized by increased proliferation and activity of T-cells and macrophages leading…Abstract Number: 2201 • 2014 ACR/ARHP Annual Meeting
Haematological Complications in Rheumatic Diseases: Not Only Lymphomas
Background/Purpose Several immunological abnormalities have been reported among patients affected by myelodisplastic syndrome (MDS). On the other hand, a relatively limited number of studies have…
ACR Meeting Abstracts